CA Patent

CA2622967A1 — A system and method for detecting an epileptic event

Assigned to Biolert Ltd · Expires 2007-03-29 · 19y expired

What this patent protects

Disclosed is a device and method for detecting and alerting of an epileptic seizure. The detector is wearable by an active user and does not interfere with normal daily movement. The detector is based on at least one motion sensor, and performs computerized analysis to determine …

USPTO Abstract

Disclosed is a device and method for detecting and alerting of an epileptic seizure. The detector is wearable by an active user and does not interfere with normal daily movement. The detector is based on at least one motion sensor, and performs computerized analysis to determine whether a seizure is occurring. The motion signal parameters are compared to non-epileptic epileptic motion signal parameters; and to epileptic parameters, and a decision is reached whether to signal an alert. In a preferred embodiment, analysis relies on one or more of the following signal parameters of the motion: the duration of the motion, the frequency of the motion, the amplitude of the signal, the direction of the motion, and the ratio of the amplitude over the frequency of the motion

Drugs covered by this patent

Patent Metadata

Patent number
CA2622967A1
Jurisdiction
CA
Classification
Expires
2007-03-29
Drug substance claim
No
Drug product claim
No
Assignee
Biolert Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.